ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 158 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 0.09 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $382,000 | -68.1% | 8,919 | -84.5% | 0.04% | -18.2% |
Q3 2018 | $1,198,000 | +24.8% | 57,727 | -8.2% | 0.04% | +29.4% |
Q2 2018 | $960,000 | -30.3% | 62,896 | +2.6% | 0.03% | -34.6% |
Q1 2018 | $1,378,000 | -21.8% | 61,319 | +4.8% | 0.05% | -23.5% |
Q4 2017 | $1,762,000 | +68.9% | 58,517 | +61.8% | 0.07% | +61.9% |
Q4 2016 | $1,043,000 | -42.6% | 36,171 | -36.7% | 0.04% | -44.7% |
Q3 2016 | $1,818,000 | +618.6% | 57,149 | +410.3% | 0.08% | +985.7% |
Q2 2014 | $253,000 | – | 11,199 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 563,200 | $16,243,000 | 9.48% |
Avoro Capital Advisors LLC | 1,486,460 | $42,870,000 | 8.66% |
Baker Brothers Advisors | 25,819,768 | $744,642,000 | 7.30% |
SECTORAL ASSET MANAGEMENT INC | 1,176,543 | $33,932,000 | 3.76% |
HARVEY CAPITAL MANAGEMENT INC | 251,825 | $7,262,000 | 3.38% |
ACUTA CAPITAL PARTNERS, LLC | 300,000 | $8,652,000 | 3.22% |
Palo Alto Investors LP | 1,532,030 | $44,184,000 | 2.52% |
Ghost Tree Capital, LLC | 350,000 | $10,094,000 | 2.43% |
EMORY UNIVERSITY | 76,121 | $2,195,000 | 2.16% |
WEATHERBIE CAPITAL, LLC | 576,784 | $16,634,000 | 2.09% |